Lannett Co., Inc.
(NYSE : LCI)

( )
LCI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
0.28%41.590.9%$960.31m
MRKMerck & Co., Inc.
0.19%78.870.6%$778.33m
JNJJohnson & Johnson
-0.15%138.400.7%$769.00m
BMYBristol-Myers Squibb Company
-1.20%46.291.4%$656.79m
LLYEli Lilly and Company
0.18%116.221.0%$521.76m
ABBVAbbVie, Inc.
0.44%79.812.2%$446.60m
NVSNovartis AG Sponsored ADR
-0.82%82.020.2%$208.94m
AZNAstraZeneca PLC Sponsored ADR
-0.64%37.541.3%$189.73m
GSKGlaxoSmithKline plc Sponsored ADR
-0.20%39.380.2%$99.07m
NVONovo Nordisk A/S Sponsored ADR Class B
0.98%47.250.1%$62.93m
SNYSanofi Sponsored ADR
-1.12%41.430.2%$47.37m
LCILannett Company, Inc.
0.00%6.0036.7%$10.13m
AKTXAkari Therapeutics Plc Sponsored ADR
-4.71%2.631.6%$3.88m
EPIXESSA Pharma Inc
0.94%2.160.1%$0.01m

Company Profile

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. Its products include aqueous vitamin D 4; escitalopram oxalate; ranitidine syrup; danazol; primidone; and isonlazid. The company was founded in 1942 and is headquartered in Philadelphia, PA.